Basic net income (loss) per share attributable to Series A and Series B common stockholders is computed by dividing the net income (loss) by the number of weighted-average outstanding common shares. Diluted net income (loss) per share attributable to Series A and Series B common stockholders is determined by giving effect to all potential common equivalents during the reporting period, unless including them yields an antidilutive result. The Company considers its warrants, Investment Option, RSUs, PSUs, stock options, and ESPP shares as potential common equivalents. The Company uses the treasury stock method for calculating any potential dilutive effect of its potential common equivalents, but excluded them from the computation of diluted earnings per share attributable to common stockholders for the three months ended June 30, 2026 and three and six months ended June 30, 2025 as the Company was in a net loss position and their effect was antidilutive.

The rights, including the liquidation and dividend rights, of the holders of Series A and Series B common stock are identical, except with respect to voting and conversion. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each series of common stock and the resulting basic and diluted net income (loss) per share attributable to common stockholders are, therefore, the same for both Series A and Series B common stock on both an individual and combined basis.

The following table presents the calculation of basic and diluted net income (loss) per share attributable to Series A and Series B common stockholders for the three and six months ended June 30, 2026 and 2025 (in thousands, except share and per share data):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Net (loss) income per share attributable to Series A and Series B common stockholders, basic:
Numerator:
Net (loss) income	$	(8,849)	$	(24,281)	$	189	$	(38,370)
Denominator:
Weighted-average shares, basic	296,851,806		284,928,388		300,597,853		279,674,052
Net (loss) income per share attributable to Series A and Series B common stockholders, basic	$	(0.03)	$	(0.09)	$	—	$	(0.14)

Net (loss) income per share attributable to Series A and Series B common stockholders, diluted:
Numerator:
Net (loss) income	$	(8,849)	$	(24,281)	$	189	$	(38,370)
Denominator:
Weighted-average shares, diluted	296,851,806		284,928,388		301,908,020		279,674,052
Net (loss) income per share attributable to Series A and Series B common stockholders, diluted	$	(0.03)	$	(0.09)	$	—	$	(0.14)


	As of June 30,
	2026	2025
Warrants outstanding	1,721,912	3,099,440
Investment Option	15,743,174	15,743,174
RSUs and PSUs outstanding	22,321,329	18,407,326
Options outstanding	—	2,579,606
ESPP	176,647	29,212
Total	39,963,062	39,858,758